DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Li G, Cook DJ, Levine MA. , et al; PROTECT Investigators for the Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group.
Australian and New Zealand Intensive Care Society Clinical Trials Group. Competing risk analysis for evaluation of dalteparin versus unfractionated heparin for venous thromboembolism in medical-surgical critically ill patients.
Medicine (Baltimore) 2015;
94 (36) e1479
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.